+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Brain Biomarkers Market by Product, Biomarker Type, Technology, Indication, End User - Global Forecast to 2030- Product Image
Brain Biomarkers Market by Product, Biomarker Type, Technology, Indication, End User - Global Forecast to 2030- Product Image
Sale

Brain Biomarkers Market by Product, Biomarker Type, Technology, Indication, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011102
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The brain biomarkers market is rapidly evolving, driven by advances in technology and shifting demands in neurological disease management. Senior decision-makers face new opportunities and strategic choices as biomarker-driven diagnostics and therapeutics change the clinical and research landscape.

Market Snapshot: Brain Biomarkers Market Growth

The Brain Biomarkers Market grew from USD 10.54 billion in 2024 to USD 12.50 billion in 2025. It is expected to continue growing at a CAGR of 17.95%, reaching USD 28.39 billion by 2030. This strong upward trajectory is propelled by accelerating adoption of high-throughput analytic technologies, the expansion of personalized medicine, and rising incidence of neurological disorders such as Alzheimer’s, Parkinson’s, and multiple sclerosis. The demand for objective, quantifiable biomarker data is shaping global investment and partnership strategies across pharmaceutical, diagnostic, and life sciences sectors.

Scope & Segmentation

  • Products: Immunoassay analyzers, PCR instruments, sequencers, immunoassay kits, PCR kits, sequencing kits, diagnostic services, research services
  • Biomarker Types: Cell-based assays, genetic markers, imaging biomarkers, metabolite markers, protein biomarkers
  • Technologies: Imaging modalities (CT, MRI, PET), immunoassays (CLIA, ELISA, lateral flow assays), mass spectrometry (LC-MS/MS, MALDI-TOF), next-generation sequencing, PCR (digital PCR, qPCR)
  • Indications: Alzheimer’s, epilepsy, multiple sclerosis, Parkinson’s, stroke, traumatic brain injury
  • End Users: Biopharmaceutical companies, diagnostic laboratories, hospitals, clinics, research institutes
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Company Coverage: F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, Abbott Laboratories, Bio-Rad Laboratories, Inc., Quanterix Corporation, Fujirebio Holdings, Inc., PerkinElmer, Inc., Bio-Techne Corporation

Key Takeaways for Senior Decision-Makers

  • Objective biomarker measurement enables earlier, more accurate diagnosis and patient stratification, supporting precision medicine strategies and optimized clinical trial enrollment.
  • Adoption of integrated platforms—combining high-throughput sequencing, mass spectrometry, and artificial intelligence—reduces diagnostic turnaround while refining assay specificity and sensitivity.
  • Collaborative efforts among biopharma, diagnostics, and academic partners are crucial to drive validation, regulatory alignment, and real-world adoption of biomarker assays.
  • Segment-specific solutions, such as cell-based assays for functional studies or protein/metabolite profiling for neurodegenerative conditions, allow providers to address both clinical and research requirements across diverse indications.
  • Regional market variations (Americas, EMEA, Asia-Pacific) present distinct regulatory, reimbursement, and infrastructure factors, requiring tailored go-to-market strategies and partnership models.

Tariff Impact and Strategic Sourcing

US tariffs enacted in 2025 have created cost pressures for global biomarker supply chains, particularly affecting the import of sequencing instruments, PCR equipment, and reagents. Laboratories and diagnostic companies are renegotiating contracts, localizing manufacturing, and leveraging bundled procurement solutions to manage increased expenses. Suppliers are refining pricing approaches and partnership structures to maintain competitive offerings, highlighting the need for diversified sourcing and resilient supplier networks.

Methodology & Data Sources

This report leverages a multifaceted research approach, including primary interviews with industry leaders and secondary analysis of peer-reviewed publications, regulatory filings, and market databases. Quantitative data are corroborated through triangulation, and validation includes expert panel reviews, trend mapping, and scenario modeling, ensuring comprehensive and reliable insight for strategic planning.

Why This Report Matters

  • Equips executives, operational leaders, and strategists with actionable intelligence to guide investment, partnership, and market-entry decisions across the evolving brain biomarkers landscape.
  • Delivers nuanced analysis of product, technology, application, and regional dynamics—enabling tailored resource allocation and risk mitigation.
  • Supports long-term planning through rigorous, evidence-based market evaluation, validated by cross-industry expertise.

Conclusion

Grounded in robust methodology and expert insight, this analysis distills the forces shaping growth in brain biomarker markets. Senior leaders can leverage these findings to optimize strategy and capture emerging opportunities in diagnostics and neuroscience innovation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Brain Biomarkers Market, by Product
8.1. Introduction
8.2. Instruments
8.2.1. Immunoassay Analyzers
8.2.2. Pcr Instruments
8.2.3. Sequencers
8.3. Kits And Reagents
8.3.1. Immunoassay Kits
8.3.2. Pcr Kits
8.3.3. Sequencing Kits
8.4. Services
8.4.1. Diagnostic Services
8.4.2. Research Services
9. Brain Biomarkers Market, by Biomarker Type
9.1. Introduction
9.2. Cell Based
9.2.1. Cell Culture Assays
9.2.2. Flow Cytometry
9.3. Genetic Biomarkers
9.3.1. Ngs Based Genetic
9.3.2. Pcr Based Genetic
9.4. Imaging Biomarkers
9.4.1. Ct
9.4.2. Mri
9.4.3. Pet
9.5. Metabolite Biomarkers
9.5.1. Gc Ms
9.5.2. Lc Ms
9.6. Protein Biomarkers
9.6.1. Blood Protein
9.6.2. Csf Protein
10. Brain Biomarkers Market, by Technology
10.1. Introduction
10.2. Imaging Modalities
10.2.1. Computed Tomography
10.2.2. Magnetic Resonance Imaging
10.2.3. Positron Emission Tomography
10.3. Immunoassays
10.3.1. Clia
10.3.2. Elisa
10.3.3. Lateral Flow Assays
10.4. Mass Spectrometry
10.4.1. Lc Ms Ms
10.4.2. Maldi Tof
10.5. Next Generation Sequencing
10.5.1. Targeted Sequencing
10.5.2. Whole Genome Sequencing
10.6. Pcr
10.6.1. Digital Pcr
10.6.2. Qpcr
11. Brain Biomarkers Market, by Indication
11.1. Introduction
11.2. Alzheimers
11.2.1. Disease Monitoring
11.2.2. Early Detection
11.2.3. Prognosis
11.3. Epilepsy
11.3.1. Disease Monitoring
11.3.2. Early Detection
11.3.3. Prognosis
11.4. Multiple Sclerosis
11.4.1. Disease Monitoring
11.4.2. Early Detection
11.4.3. Prognosis
11.5. Parkinsons
11.5.1. Disease Monitoring
11.5.2. Early Detection
11.5.3. Prognosis
11.6. Stroke
11.6.1. Disease Monitoring
11.6.2. Early Detection
11.6.3. Prognosis
11.7. Traumatic Brain Injury
11.7.1. Disease Monitoring
11.7.2. Early Detection
11.7.3. Prognosis
12. Brain Biomarkers Market, by End User
12.1. Introduction
12.2. Biopharmaceutical Companies
12.2.1. Biotechnology Firms
12.2.2. Large Pharma
12.3. Diagnostic Laboratories
12.3.1. Independent Laboratories
12.3.2. Reference Laboratories
12.4. Hospitals And Clinics
12.4.1. Specialty Clinics
12.4.2. Tertiary Care Centers
12.5. Research Institutes
12.5.1. Academic Institutions
12.5.2. Contract Research Organizations
13. Americas Brain Biomarkers Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Brain Biomarkers Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Brain Biomarkers Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Siemens Healthineers AG
16.3.3. Thermo Fisher Scientific Inc.
16.3.4. Danaher Corporation
16.3.5. Abbott Laboratories
16.3.6. Bio-Rad Laboratories, Inc.
16.3.7. Quanterix Corporation
16.3.8. Fujirebio Holdings, Inc.
16.3.9. PerkinElmer, Inc.
16.3.10. Bio-Techne Corporation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. BRAIN BIOMARKERS MARKET MULTI-CURRENCY
FIGURE 2. BRAIN BIOMARKERS MARKET MULTI-LANGUAGE
FIGURE 3. BRAIN BIOMARKERS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. BRAIN BIOMARKERS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. BRAIN BIOMARKERS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BRAIN BIOMARKERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRAIN BIOMARKERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SEQUENCING KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CELL CULTURE ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NGS BASED GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR BASED GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PET, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY GC MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LC MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BLOOD PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CSF PROTEIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CLIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LC MS MS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY QPCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, BY REGION, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DISEASE MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY EARLY DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY PROGNOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 97. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 99. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 100. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 101. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 102. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 103. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 104. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 105. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 106. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 107. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 108. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY TERTIARY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 109. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 110. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 111. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 112. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 113. GLOBAL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 121. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 122. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 123. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 124. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 126. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 127. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 128. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 129. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 130. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 132. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 133. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 134. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 135. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 136. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 137. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 139. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 140. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 141. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 142. AMERICAS BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 145. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 146. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 147. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 149. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 150. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 151. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 152. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 153. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 155. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 156. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 157. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 158. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 159. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 160. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 161. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 162. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES BRAIN BIOMARKERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 172. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 173. CANADA BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 174. CANADA BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. CANADA BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 176. CANADA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 177. CANADA BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 178. CANADA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 179. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 180. CANADA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 181. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 182. CANADA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 183. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 184. CANADA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 185. CANADA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 186. CANADA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 187. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 188. CANADA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 189. CANADA BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 190. CANADA BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 191. CANADA BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 192. CANADA BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 193. CANADA BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 194. CANADA BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 195. CANADA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. CANADA BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 197. CANADA BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 198. CANADA BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 199. CANADA BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 200. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 201. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 202. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 204. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 205. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 206. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 207. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 208. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 209. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 212. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 213. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 214. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 215. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 216. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 217. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 218. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 219. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 220. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 221. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 222. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 223. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 225. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 226. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 227. MEXICO BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 228. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 230. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 231. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 232. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 233. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 234. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 235. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 236. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 237. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 238. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 240. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 241. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 242. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 243. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 244. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 245. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 246. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 247. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 248. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 249. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 250. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 251. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 253. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 254. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 255. BRAZIL BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 256. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 257. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 258. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 259. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 260. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 261. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 262. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 263. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 264. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 265. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 266. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 268. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 269. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 270. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 271. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 272. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 273. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 274. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 275. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 276. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 277. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 278. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 279. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 281. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 282. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 283. ARGENTINA BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 300. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 301. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 302. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 303. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 304. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 305. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 306. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 307. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 309. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 310. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA BRAIN BIOMARKERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 313. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 314. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 315. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY KITS AND REAGENTS, 2018-2030 (USD MILLION)
TABLE 316. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY BIOMARKER TYPE, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY CELL BASED, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY GENETIC BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY IMAGING BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY METABOLITE BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY PROTEIN BIOMARKERS, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY IMAGING MODALITIES, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY IMMUNOASSAYS, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2030 (USD MILLION)
TABLE 328. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY PCR, 2018-2030 (USD MILLION)
TABLE 329. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 330. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY ALZHEIMERS, 2018-2030 (USD MILLION)
TABLE 331. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY EPILEPSY, 2018-2030 (USD MILLION)
TABLE 332. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2030 (USD MILLION)
TABLE 333. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY PARKINSONS, 2018-2030 (USD MILLION)
TABLE 334. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY STROKE, 2018-2030 (USD MILLION)
TABLE 335. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY TRAUMATIC BRAIN INJURY, 2018-2030 (USD MILLION)
TABLE 336. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 337. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 338. UNITED KINGDOM BRAIN BIOMARKERS MARKET SIZE, BY D

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Brain Biomarkers market report include:
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Quanterix Corporation
  • Fujirebio Holdings, Inc.
  • PerkinElmer, Inc.
  • Bio-Techne Corporation

Table Information

Report AttributeDetails
No. of Pages190
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 28.39 Billion
Compound Annual Growth Rate17.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030 - Product Image

Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End Use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Brain Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Brain Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Neurological Biomarkers Market Report by Type, Application, End Use, and Region 2024-2032 - Product Image

Neurological Biomarkers Market Report by Type, Application, End Use, and Region 2024-2032

  • Report
  • 142 Pages
  • Global
From
Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 181 Pages
  • Global
From
Neurological Biomarkers - Global Strategic Business Report - Product Image

Neurological Biomarkers - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From

About the Neurological Biomarker Market

A neurological biomarker is a biological indicator of a neurological disorder or disease. It is used to diagnose, monitor, and predict the progression of neurological diseases. Neurological biomarkers can be found in a variety of biological samples, such as blood, cerebrospinal fluid, and tissue. They can also be used to measure the effectiveness of treatments. Neurological biomarkers are becoming increasingly important in the field of personalized medicine, as they can provide a more accurate diagnosis and prognosis of neurological diseases. They can also be used to identify potential drug targets and to monitor the progression of neurological diseases. The neurological biomarker market is growing rapidly, driven by the increasing prevalence of neurological diseases, the development of new technologies, and the increasing demand for personalized medicine. The market is expected to continue to grow in the coming years, as more companies enter the market and develop new technologies. Some of the major companies in the neurological biomarker market include Bio-Rad Laboratories, Inc., BioMérieux SA, Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.